Substituted Benzyloxypyrimidines and Their Inactivation of O.sup.6 -Alkylguanine-Dna Alkyltransferase

Patent Citations (15)

Non-Patent Literature (104)

• Harnden et al., "Synthesis and Antiviral Activity of 9-›4-hydroxy-3-(hydroxymethyl)but-1-yl!purines," J. Med. Chem., 30, 1636-1642 (1987).
• Beaman et al., in Zorbach and Tipson, Synthetic Procedures in Nucleic Acid Chemistry, vol. 1, pp. 41-43 (John Wiley & Sons, New York, NY, 1968).
• Boon et al., J. Chem. Soc., pp. 96-102 (1951).
• Chae et al., J. Med. Chem., 37, 342-347 (1994).
• Chae et al., J. Med. Chem., 38, 359-365 (1995).
• Crone et al., Cancer Res., 53, 4750-4753 (1993).
• Daves, Jr., et al., J. Am. Chem. Soc., 82, 2633-2640 (1960).
• Delia et al., Heterocycles, 20, 1805-1809 (1983).
• Dolan et al., Proc. Natl. Acad. Sci. U.S.A., 87, 5368-5372 (1990).
• Dolan et al., Cancer Commun.,2, 371-377 (1990).
• Dolan et al., Cancer Res., 51, 3367-3372 (1991).
• Dolan et al., Biochem. Pharmacol., 46, 285-290 (1993).
• Dolan et al., Cancer Chem. Pharmacol., 32, 221-225 (1993).
• Felker et al., Cancer Chem. Pharmacol., 32, 471-476 (1993).
• Friedman et al., J. Natl. Cancer Inst., 84, 1926-1931 (1992).
• Gerster et al., J. Am. Chem. Soc., 87, 3752-3759 (1965).
• Jones et al., J. Am. Chem. Soc., 82, 3773-3779 (1960).
• Kosary et al., Acta Pharm. Hung., 49, 241-247 (1989).
• Mitchell et al., Cancer Res., 52, 1171-1175 (1992).
• Moschel et al., J. Med. Chem., 35, 4486-4491 (1992).
• Moschel et al., J. Org. Chem., 51, 4180-4185 (1986).
• O'Brien et al., J. Med. Chem., 9, pp. 573-575 (1966).
• Pfleiderer et al., Chem. Ber., 94, 12-18 (1961).
• Pfleiderer et al., Liebigs Ann. Chem., 726, 201-215 (1969).
• Philips et al., J. Org. Chem., 28, 1488-1490 (1963).
• Ram et al., Chem. Abstr., 101, 230466q (1984).
• Robins et al., J. Org. Chem., 34, 2160-2163 (1969).
• Shealey et al., J. Org. Chem., 27, 4518-4523 (1962).
• Wakabayashi et al., Nippon Dojo-Hiryyogaku Zasshi, 41, 193-200 (1970) (Abstract CA73: 108869m).
• Wasserman et al., Cancer, 36, 1258-1268 (1975).
• Beecham Group, "Preparation of Guaninie Derivatives and Their Use in Antiviral Preparations," 28-Heterocyles, 103:123509a (1985).
• Biasacchi et al., Preparation of ›1.beta.-(1.alpha.,2.beta.,3.alpha.)!-2-amino-9-›2,3-=bis(hydroxymethyl)cy clobutyl!-6H-purin-6-one, Chem. Abs., 115:159683q.
• Biasacchi et al., Synthesis and Antiviral Activity of Enantiomeric Forms of Cyclobutyl Nucleoside Analogues, J. Med. Chem., 34, 1415-1421 (1991).
• Bowles et al., "Synthesis and Antitumor Activity of 9-(Tetrahydro-2-furyl)purine Analogs of Biologically Important Deoxynucleosides," . Med. Chem., 6, 471-480 (1963).
• Brix et al., "Androgen-linked Alkylating Agents: Biological Activity in Methylnitrosourea-induced Rat Mammary Carcinoma," J. Cancer Res. Clinical Oncology, 116, 538-549 (1990).
• Carbon et al., "Synthesis and Reactions of 5-Bromomethyl-and 5-Chloromethyluracil," J. Org. Chem., 25, 1731-1734 (1960).
• Dolan et al., "Depletion of O.sup.6 -alkylguanine-DNA Alkyltransferase Activity in Mammalian Tissues and Human Tumor Xenografts in Nude Mice by Treatment with O.sup.6 -methylguanine," Cancer Chemother. Pharmacol., 25, 103-108 (1989).
• Dolan et al., "Effect of O.sup.6 -Alkylguanine Pretreatment on the Sensitivity of Human Colon Tumor Cells to the Cytotoxic Effects of Chloethylating Agents," Cancer Research, 46, 4500-4505 (1986).
• Dolan et al., "Comparison of the Inctivation of Mammalian and Bacterial O.sup.6 -Alkylguanine-DNA Alkyltransferases by O.sup.6 -Benzylguanine and O.sup.6 -Methylguanine," Carcinogenesis, 12 (12), 2305-2309 (1991).
• Dorr et al. in Cancer Chemotherapy Handbook, 715-742 (Elsevier Science Publishing, New York, NY 1980).
• Fischer et al. in Cancer Chemotherapy Handbook, 3rd ed., 4-9, 60-61, 164-165, 171 (Year Book Medical Publishers, Inc., Chicago, IL 1989).
• Folkman et al., "A New One-Step Method for the Preparation of 3',5'-Bisphosphates of Acid-Labile Deoxynucleosides," Chem. Res. Toxicol., 3, 536-539 (1990).
• Fondy et al., "Haloacetamido Analogues of 2-Amino-2-deoxy-D-glucose and 2-Amino-2-deoxy-D-galactose. Syntheses and Effects on the Friend Murine Erythroleukemia," J. Med. Chem., 21 (12), 1222-1225 (1978).
• Ford et al., "A Simple Method for Predicting Hydration Energies of Organic Cations Derived from Protonation of Alkylation of Neutral Oxygen and Nitrogen Bases," J. Org. Chem., 48 (13), 2226-2233 (1983).
• Frihart et al., "Allylic Rearrangement from O.sup.6 to C-8 in the Guanine Series," J. Am. Chem. Soc., 95 (21), 7174-7175 (1973).
• Gerson et al., "Synergistic Efficacy of O.sup.6 -Benxzylguanine and 1,3-Bis(2-Chloroethyl=-Nitrosourea (BCNU) in a Human Colon Cancer Xenograft Completely Resistant to BCNU Alone," Biochem. Pharmacol., 45 (2), 483-491 (1993).
• Green et al., "Preparation of Purine Acyclonucleoside Intermediates," Chem. Abs., 115:28993t (1991).
• Hagberg et al., "Guanine Derivatives," Chem. Abs., 97:182809d (1982).
• Hannah et al., "Substituted Butylguanines and Their Utilization in Antiviral Compositions," 26-Biomolecules, 104:68682 (1986).
• Hannah et al., "Carba-acylonucleoside Antiherpetic Agents," J. Heterocyclic Chem., 26, 1261-1271 (1989).
• Harnden et al., "Prodrugs of the Selective Antiherpesvirus Agent 9-›4-Hydroxy-3-(hydroxymethyl)but-1-yl! guanine (BRL 39123) with Improved Gastrointestinal Absorption Properties," J. Med. Chem., 32, 1738-1743 (1989).
• Harrison's Principles of Internal Medicine, 10th ed., 751, 758, 766-775 (1983).
• Himmelsback et al., "The p-Nitrophenylethyl (NPE) Group. A Versatile New Blocking Group for Phosphate and Aglycone Protection in Nucleosides and Nucleotides," Tet., 40 (1), 59-72 (1984).
• Holmes et al., "Rearrangement of Cinnamyl Groups from O.sup.6 to C-8 in the Guanine Series," J. Org. Chem., 43 (3), 516-518 (1978).
• House in Modern Synthetic Reactions, 2nd ed., 536-541, 602-603 (1972).
• Jacobs et al., "Synthesis of SQ-32,829, A New Nucleoside Antiviral Agent," Tet. Letters, 30 (50), 6955-6958 (1989).
• Karkas et al., "Enzymatic Phosphorylation of the Antiherpetic Agent 9-›2,3-Dihydroxy-1-propoxy)methyl! guanine," J. Med. Chem., 29 (5), 842-848 (1986).
• Kim et al., "Acyclic Purine Phosphonate Analogues as Antiviral Agents. Syntheisis and Structure-Activity Relationships," J. Med. Chem., 33, 1207-1213 (1990).
• Kjellberg et al., "Regioselective Alkylation of 6-(8-Methoxyethoxy) Guanine to Give the 9-Alkylguanine Derivative," Tet. Letters, 27 (7), 877-880 (1986).
• Kusmiesek et al., "Synthesis of N.sup.2,3-Ethenodeoxyguanosine, N.sup.2,3-Ethenodeoxyguanosine 5'-Phosphate, and N.sup.2,3-Ethenodeoxyguanosine 5'-Triphosphate. Stability of the Glycosyl Bond in the Monomer and in Poyl(dG,.epsilon.dG-dC)," Chem. Res. Toxicol., 2, 230-233 (1989).
• Leonard et al., "Intramolecular Mechanism of the Allylic Rearrangement from O.sup.6 to C-8 in the Guanine Series Double Labeling Experiments," J. Am. Chem. Soc., 96, 5894-5903 (1974).
• March in Advanced Organic Chemistry, 3rd ed., 358-359, 574-575, 802-803, 982-985 (John Wiley & Sons 1985).
• MacCoss et al., "Regioselective Synthesis of 9-Substituted Purine Acyclonucleoside Derivatives," Chem. Abs., 105:115383f (1986).
• MacCoss et al., "Synthesis of the Chiral Acyclonucleoside Antiherpetic Agent (S)-9-(2,3-Dihydroxy-1-Propoxymethyl)guanine," Tet. Letters, 26 (15), 1815-1818 (1985).
• Mansuri et al., "Preparation of 4-phosphoromethoxycyclopent=(en)-1-ylpurines and -pyrimidines as Virucides, Bactericides, and Neoplasm Inhibitors," Chem. Abs., 113:152983n (1990).
• Milne et al., "Synthesis and Antitumor Activity of .alpha.-and .beta.-2'-Deoxy-6-selenoguanosine and Certain Related Derivatives," J. Med. Chem., 17 (3), 263-268 (1974).
• Moschel et al., "Reactivity Effects on Site Selectivity in Nucleoside Aralkylation: A Model for the Factors Influencing the Sites of Carcinogen-Nucleic Acid Interactions," 33-Carbohydrates, 107:115902r (1989).
• Moschel et al., "Sustituted-Induced Effects on the Stability of Benzylated Guanosines: Model Systems for the Factors Influencing the Stability of Carcinogen-Modified Nucleic Acids," J. Org. Chem., 49 (2), 363-372 (1984).
• Murray, "Dioxiranes," Chem. Rev., 89 (5), 1187-1201 (1989).
• Pansare et al., "Synthesis of N-Protected .alpha.-Amino Acids from N-(Benzyloxycarbonyl)-L-Serine Via Its .beta.-Lactone: N.sup..alpha. -(Benzyloxycorbonyl)-.beta.-(Pyrazol-1-Y1)-L-Alanine," Organic Syntheses, 70 (1), 1-9 (1992).
• Pansare et al., "Synthesis of N-tert-Butoxycarbonyl-L-Serine .beta.-Lactone and the p-Toluenesulfonic Acid Salt of (S)-3-Amino-2-Oxetanone," Organic Syntheses, 70, 10-17 (1992).
• Pauly et al., "A Sectored Colony Assay for Monitoring Mutagenesis by Specific Carcinogen-DNA Adducts in Escherichia coli," Biochemistry, 30 (50), 11700-11706 (1991).
• Pauly et al., "Synthesis and Properties of H-ras DNA Sequences Containing O.sup.6 -Substituted 2'-Deoxyguanosine Residues at the First,Second, or Both Positions of Codon 12," Chem. Res. In Toxic., 1 (6), 391-397 (1988).
• Pegg et al., "Use of Antibodies to Human O.sup.6 -alkylguanine-DNA Alkyltransferase to Study the Content of This Protein in Cells Treated with O.sup.6 -Benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine," Carcinogenesis, 12 (9), 1679-1683 (1991).
• Ramzaera et al, "Alkalation of 6-methylthio-and 6-benzyloxyguanine under Phase-Transfer Conditions," Synth. Commun., 19 (18), 3121-3128 (1989).
• Rideout et al., "Perparation of (3'-azido-2',3'-dideoxy) Purine Nucleosides as Medical Antivirals," Chem. Abs., 116:84108r (1992).
• Robins et al., "Purine Nucleosides. XXIV. A New Method for the Synthesis of Guanine Nucleosides. Preparation of 2'-deoxy-.alpha.-and -.beta.-guanosines and the Corresponding N.sup.2 -methyl derivatives," 34-Synthesis of Amino Acids, Peptides and Proteins, 71:39386 (1969).
• Schaffer et al., "Substituted Purine Derivatives," Chem. Abs., 84:180300p (1976).
• Schaffer et al., "Compositions for Treating Viral Infections and Guanine Acyclic Nucleosides," Chem. Abs., 93:186414m (1980).
• Skinner, Jr., "Potential Anticancer Agents XXVIII. Synthesis of 5-(Chloromethyl)uraeil," Org. Chem., 25, 149-151 (1960).
• Slusarchyk et al., "Preparation of ›bis(hydroxymethyl)cyclobutyl!=Purines and -pyrimidines as Virucides," Chem. Abs., 112:179713v (1990).
• Slusarchyk et al., "Preparation of 7-›3-(hydroxymethyl)cyclobutyl! Purines and -pyrimidines as Antiviral Agents," Chem. Abs., 113:40344y (1990).
• Slusarchyk et al., "Synthesis of SQ-33,054, A Novel Cyclobutane Nucleoside with Potent Antiviral Activity," Tet. Letters, 30 (47), 6453-6456 (1989).
• Stein et al., "Inhibition of Human Purine Nucleoside Phosphorylase by Acyclic Nucleosides and Nucleotides," Biochem Pharmacol., 36 (8), 1237-1244 (1989).
• Tisdale et al., "Preparatin of 2'-deoxy-2'-fluororibonucleosides as Medicinal Virucides," Chem. Abs., 115:230514t (1991).
• Tichtinger et al., "Synthesis of O.sup.6 -p-Nitrophenylethyl Guanosine and 2'-Deoxyguanosine Derivatives," Tet. Letter, 24 (7), 711-714 (1983).
• Tolman et al., "4-(Guanin-9-yl)butanals and Antiviral Compositions Containing Them," Chem. Abs., 105::114840r (1986).
• Tolman et al., "9-›2-(Hydroxymethyl)cycloalkylmethyl!guainines as Antiviral Agents and Their Preparation," 26-Biomolecules, 110:212501d (1989).
• Tondeur et al., "Fast Atom Bombardment and Collisional Acitvation Mass Spectrometry as Probes for the Identification of Positional Isomers in a Series of Benzylated Guanosines," Chem. Abs., 104:199241y (1986).
• Vemishetti et al., "Synthesis of Chiral 1',2'-Seco-Nucleosides of Guanine and Uracil," Nucleosides and Nucleotides, 8 (2), 201-211 (1989).
• Vemishetti et al., "The Preparation of 2'-Deoxy-2'-fluoro-1',2'-seconucleosides as Potential Antiviral Agents," J. Med. Chem., 33, 681-686 (1990).
• Wallace, Raymond, "Hydroxylamine-O-sulfonic Acid -A Versatile Synthetic Reagent," Aldrichimia Acta, 13, 3-11 (1980).
• Webb et al., "Antiviral Phosphonomethoxyalkylpurines and -pyrimidines and their Preparation," 26-Biomolecules, 109:190136 (1988).
• Webb et al., "Preparation of ›(purin-9-ylalkoxy)methyl!phos=phonic Acids as Antiviral Agents," Chem. Abs., 111:39105y (1989).
• Wilson, "Synthetic Approaches to a Carboranyl Thioracil," Pigment Cell Research, 2, 297-303 (1989).
• Winograd et al., "Human Tumor Xenografts in the Nude Mouse and their Value as Test Models in Anticancer Drug Development (Review)," In Vivo, 1, 1-14 (1987).
• Yu et al., "Preparation of Chiral 2-(phosphonomethyoxy)pro=pylguanines as Antiviral Agents," Chem. Abs., 116:41987j (1992).
• Zahler et al., "Preparation of Purinyl-and Pyrimidinylcyclo=butanes as Antiviral Agents," Chem.Abs., 112:158265f (1990).
• Zahler et al., Purinyl-and Pyrimidinylcyclobutanes and Their Use as Antiviral Agents, Chem.Abs., 113:152981k (1990).
• Zahler et al., "Preparation of Virucidal Purinyl-and Pyrimidi=nyl-tetrahydrofurans," 33-Carbohydrates, 114:122985t (1991).
• Zahler et al., "Preparation of 4,5-bis(hydroxymethyl)tetrahydro=furan-3-ylpurines and Pyrimidines as Virucides," 33-Carbohydrates, 116:84113p (1991).
• CA 72:100650, 1970.
• CA 107:194511, 1987.
• CA 112:216531, 1989.